Securities Code: 301520
Securities Abbreviation: Wanbang Pharmaceutical
Announcement Number: 2026-023
Anhui Wanbang Pharmaceutical Technology Co., Ltd.
Announcement on Abnormal Stock Trading Fluctuations
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
I. Description of Abnormal Stock Trading Fluctuations
Anhui Wanbang Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") (Securities Abbreviation: Wanbang Pharmaceutical, Securities Code: 301520) experienced a cumulative stock price increase deviation of over 30% for two consecutive trading days (June 29, 2026, and June 30, 2026). According to the "Trading Rules of the Shenzhen Stock Exchange" and other relevant regulations, this constitutes abnormal stock trading fluctuations.
II. Company's Attention and Verification of the Situation
In response to the abnormal stock trading fluctuations, the Company's Board of Directors conducted a self-inspection of relevant matters and verified with the Company's controlling shareholders, actual controllers, all directors, and senior management. The relevant situation is hereby described as follows: